Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
DRUGNAME | PT | EventCount |
---|---|---|
RITUXIMAB | Steatohepatitis | 1 |
RITUXIMAB | Streptococcal bacteraemia | 1 |
RITUXIMAB | Streptococcus test positive | 1 |
RITUXIMAB | Subarachnoid haemorrhage | 1 |
RITUXIMAB | Subdural haematoma | 1 |
Rituximab | Superinfection | 1 |
Rituximab | Superior vena cava syndrome | 1 |
RITUXIMAB | Supraventricular tachycardia | 1 |
Rituximab | Suspected transmission of an infectious agent via product | 1 |
RITUXIMAB | Swelling | 1 |
Rituximab | Synovectomy | 1 |
Rituximab | Systemic lupus erythematosus | 1 |
RITUXIMAB | Systemic mycosis | 1 |
Rituximab | Tendon rupture | 1 |
Rituximab | Tendon sheath incision | 1 |
RITUXIMAB | Therapy cessation | 1 |
RITUXIMAB | Thrombotic thrombocytopenic purpura | 1 |
Rituximab | Thyroid cancer | 1 |
RITUXIMAB | Tinnitus | 1 |
RITUXIMAB | Transaminases abnormal | 1 |
Total Records: 1,104 Number of Pages: 56